Suppr超能文献

外泌体竞争性内源性 RNA(ceRNA)在恶性肿瘤诊断和治疗中的作用。

Role of exosomal competitive endogenous RNA (ceRNA) in diagnosis and treatment of malignant tumors.

机构信息

Department of Otorhinolaryngology-Head and Neck Surgery, Lihuili Hospital of Ningbo University, Ningbo, China.

Department of Otorhinolaryngology, NingboNo.6 Hospital Ningbo, China.

出版信息

Bioengineered. 2022 May;13(5):12156-12168. doi: 10.1080/21655979.2022.2073130.

Abstract

Malignant tumors are a threat to human health, thus it is critical to better understand the mechanism of tumor occurrence and development and to find key therapeutic targets. Competitive endogenous RNA (ceRNA) is a type of RNA molecule that includes mRNA of coding-protein, pseudogenes, long non-coding RNA (lncRNA), and circular RNA (circRNA) etc. It is created through a competitive combination of common small RNA (miRNA) and has an inhibitory effect on mRNA translation. ceRNA regulate the post transcriptional expression of genes by competitively binding to common microRNAs (miRNAs).Studies have shown that cernas are involved in tumor cell proliferation, invasion and migration, drug resistance, angiogenesis, as well as tumor immunity, and so on, affecting the progression of tumor development. This article reviews the reported roles of exosomal ceRNA in the diagnosis and treatment of malignant tumors and the mechanisms underlying these.

摘要

恶性肿瘤是危害人类健康的重大疾病,因此深入了解肿瘤发生发展的机制并寻找关键治疗靶点至关重要。竞争性内源 RNA(ceRNA)是一种 RNA 分子,包含编码蛋白的 mRNA、假基因、长链非编码 RNA(lncRNA)和环状 RNA(circRNA)等。它通过与常见的小分子 RNA(miRNA)的竞争结合而产生,对 mRNA 翻译具有抑制作用。ceRNA 通过竞争性结合共同的 microRNA(miRNAs)来调节基因的转录后表达。研究表明,ceRNA 参与肿瘤细胞的增殖、侵袭和迁移、耐药性、血管生成以及肿瘤免疫等过程,影响肿瘤发展的进程。本文综述了外泌体 ceRNA 在恶性肿瘤的诊断和治疗中的作用及其相关机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6eb4/9275901/87a312faa2af/KBIE_A_2073130_UF0001_OC.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验